Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cytokinetics Inc (CYTK)

  • Event
  • Dec. 12, 2022, 04:00 UTC
  • 154

Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND

Comment Full text

Cytokinetics Inc (CYTK)

  • Event
  • Dec. 12, 2022, 04:00 UTC
  • 82

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Comment Full text

Equillium Inc. (EQ)

  • Event
  • Dec. 11, 2022, 02:06 UTC
  • 80

Equillium - Equillium Corporate Presentation

Comment Full text

Exact Sciences Corporation (EXAS)

  • Event
  • Dec. 09, 2022, 18:05 UTC
  • 82

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

Comment Full text

Cytokinetics Inc (CYTK)

  • Event
  • Dec. 09, 2022, 17:01 UTC
  • 82

Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil

Comment Full text

QuantumSi Inc (QSI)

  • Event
  • Dec. 08, 2022, 16:01 UTC
  • 75

Quantum-Si Joins Human Proteome Organization (HUPO) Industrial Advisory Board

Comment Full text

Cytokinetics Inc (CYTK)

  • Event
  • Dec. 08, 2022, 15:30 UTC
  • 76

Cytokinetics Presents Data at the Virtual 33rd International Symposium on ALS/MND

Comment Full text

Puma Biotechnology Inc (PBYI)

  • Event
  • Dec. 08, 2022, 03:40 UTC
  • 79

Puma Biotechnology, Inc. - San Antonio Breast Cancer Symposium

Comment Full text

Cytokinetics Inc (CYTK)

  • Event
  • Dec. 07, 2022, 15:30 UTC
  • 80

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136

Comment Full text

Evaxion Biotech A/S (EVAX)

  • Event
  • Dec. 07, 2022, 12:06 UTC
  • 78

Evaxion Biotech - Corporate Presentation

Comment Full text
  • 1
  • 2
  • 3
  • Next

Search

News categories

  • Technical Exchange News(9038)
  • Event(407)
  • SEC News(142463)
  • FDA Approval(8415)
  • Company Report(721)
  • Business News(99864)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin